Validated xenograft

Tuesday, 21 June 2011 07:50 frontend

Crown Bioscience has established multiple in vivo assay systems to evaluate novel anti-cancer compounds. Each assay is designed to understand specific aspects of drug property and its mechanism of action. By accessing our comprehensive capability, our customers can advance development programs in a timely and cost-effective manner. Our highly experienced preclinical team is; focused solely on oncology, works with you to choose the most appropriate study design and screening method for an investigational agent.

Oncology Experts

ValidatedXeno^TM

• Subcutaneous Tumor Xenografts View images 1
• Orthotopic Tumor models View images 1, 2, 3, 4
• Syngeneic Tumor models

Premium Efficacy Models

• Metastatic Tumor Models View images 1, 2, 3
• Angiogenesis Models View images 1, 2, 3
• Combination Chemotherapeutic Models View image

AdvantageServices^TM

• Maximum Tolerated Dose Determinations
• In Vitro IC50 Determination
• Biomarker Services

HuPrime Tumorgraft – Genome-defined human primary tumor models